JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

Search

Quanterix Corp

Fermé

SecteurSoins de santé

3.34 3.41

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.13

Max

3.36

Chiffres clés

By Trading Economics

Revenu

10M

-23M

Ventes

3.7M

44M

Marge bénéficiaire

-52.712

Employés

450

EBITDA

15M

-17M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+64.67% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-141M

155M

Ouverture précédente

-0.07

Clôture précédente

3.34

Sentiment de l'Actualité

By Acuity

50%

50%

177 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Neutral Evidence

Quanterix Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 avr. 2026, 23:33 UTC

Actions en Tendance

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

28 avr. 2026, 23:24 UTC

Résultats

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

28 avr. 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

28 avr. 2026, 22:46 UTC

Résultats

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

28 avr. 2026, 22:37 UTC

Résultats

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

28 avr. 2026, 22:15 UTC

Résultats
Principaux Événements d'Actualité

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

28 avr. 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

28 avr. 2026, 23:31 UTC

Résultats

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

28 avr. 2026, 23:31 UTC

Résultats

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

28 avr. 2026, 23:30 UTC

Résultats

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

28 avr. 2026, 23:30 UTC

Résultats

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

28 avr. 2026, 23:19 UTC

Market Talk
Résultats

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

28 avr. 2026, 23:09 UTC

Résultats

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

28 avr. 2026, 23:03 UTC

Market Talk

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR Sees One Rate Rise to 4% in Benign Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

28 avr. 2026, 22:51 UTC

Résultats

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 avr. 2026, 22:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 avr. 2026, 22:48 UTC

Market Talk

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

28 avr. 2026, 22:40 UTC

Market Talk
Principaux Événements d'Actualité

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

28 avr. 2026, 22:32 UTC

Résultats

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

28 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

Pernod Ricard and Brown-Forman End Deal Talks -- Update

28 avr. 2026, 22:22 UTC

Résultats

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

28 avr. 2026, 22:17 UTC

Market Talk

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

28 avr. 2026, 22:14 UTC

Résultats

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

28 avr. 2026, 22:14 UTC

Résultats

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

28 avr. 2026, 22:07 UTC

Market Talk
Principaux Événements d'Actualité

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Comparaison

Variation de prix

Quanterix Corp prévision

Objectif de Prix

By TipRanks

64.67% hausse

Prévisions sur 12 Mois

Moyen 5.5 USD  64.67%

Haut 7 USD

Bas 4 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

5.34 / 6.015Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Bullish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

177 / 348Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat